Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

Scholar Rock (SRRK) announced that new efficacy and safety data from the Phase 3 pivotal SAPPHIRE trial will be presented in multiple clinical ...

Dark matter could be an entire dark sector of the universe, with its own particles and forces H ave you ever stood by the sea ...

“A new era in genetic testing has arrived,” said Carlos Bustamante, Ph.D., CEO & Co-Founder, Galatea Bio. “StrataRisk PRS empowers clinical genetic labs to deliver more informative reports to ...

As a scientist, there’s this energy you get from going to a scientific conference, where you get to nerd out with your people ...

The EU's retaliatory tariffs will now take effect in mid-April to allow time for talks with the U.S., officials said.

Sitryx CEO Iain Kilty describes the biopharmaceutical industry effort to go beyond immunosuppression in autoimmune and ...

Two pivotal trials of the aldosterone synthase inhibitor have shown positive results for lorundrostat in uncontrolled and ...

Q4 2024 Earnings Conference Call March 20, 2025 4:30 PM ETCompany ParticipantsCarlo Broos - Interim Chief Financial ...